Symbols / MPT Stock $5.14 -1.34% Medical Properties Trust, Inc.

Real Estate • REIT - Healthcare Facilities • United States • NYQ
MPT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Real Estate
Industry REIT - Healthcare Facilities
CEO Mr. Edward K. Aldag Jr.
Exch · Country NYQ · United States
Market Cap 3.15B
Enterprise Value 12.30B
Income -277.94M
Sales 1.07B
FCF (ttm) 872.72M
Book/sh 7.71
Cash/sh 0.91
Employees 121
Insider 10d —
IPO Jul 08, 2005
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 10.55%
P/E —
Forward P/E 38.07
PEG 1.61
P/S 2.94
P/B 0.67
P/C —
EV/EBITDA 13.51
EV/Sales 11.50
Quick Ratio 1.63
Current Ratio 1.94
Debt/Eq 212.09
LT Debt/Eq —
EPS (ttm) -0.46
EPS next Y 0.14
EPS Growth —
Revenue Growth 25.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-19
ROA 2.72%
ROE -5.85%
ROIC —
Gross Margin 96.11%
Oper. Margin 65.62%
Profit Margin -25.90%
Shs Outstand 612.94M
Shs Float 491.21M
Insider Own 17.41%
Instit Own 59.21%
Short Float 29.69%
Short Ratio 25.09
Short Interest 137.17M
52W High 6.47
vs 52W High -20.56%
52W Low 3.95
vs 52W Low 30.13%
Beta 1.50
Impl. Vol. 62.89%
Rel Volume 0.47
Avg Volume 6.27M
Volume 2.97M
Target (mean) $5.86
Tgt Median $5.00
Tgt Low $5.00
Tgt High $8.00
# Analysts 7
Recom Hold
Prev Close $5.21
Price $5.14
Change -1.34%
About

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 388 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of September 30, 2025. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Medical Properties Trust, Inc. was incorporated in 2003.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.86
Mean price target
2. Current target
$5.14
Latest analyst target
3. DCF / Fair value
$25.63
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.14
Low
$5.00
High
$8.00
Mean
$5.86

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-02 main RBC Capital Sector Perform → Sector Perform $5
2025-11-25 main Wells Fargo Underweight → Underweight $5
2025-08-27 main Wells Fargo Underweight → Underweight $5
News
RSS: Latest MPT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-18 HANNA JAMES KEVIN Officer — 112,500 $0.00 $0
2026-03-18 PORTAL LARRY H Chief Executive Officer — 112,500 $0.00 $0
2026-03-18 HOOPER ROSA HANDLEY Officer — 63,750 $0.00 $0
2026-03-18 LAMBERT CHARLES R Officer and Treasurer — 75,000 $0.00 $0
2026-01-08 THOMPSON C REYNOLDS III Director — 30,303 $0.00 $0
2026-01-08 MURPHY EMILY WEBSTER Director — 30,303 $0.00 $0
2026-01-08 SPARKS DANIEL PAUL Director — 30,303 $0.00 $0
2026-01-08 PITMAN ELIZABETH N Director — 30,303 $0.00 $0
2026-01-08 MOZINGO CATERINA ARDON Director — 30,303 $0.00 $0
2026-01-08 DAWSON G STEVEN Director — 30,303 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
972.02
-2.36%
995.55
+14.19%
871.80
-43.49%
1,542.85
Operating Revenue
972.02
-2.36%
995.55
+14.19%
871.80
-43.49%
1,542.85
Cost Of Revenue
36.41
+33.61%
27.25
-34.43%
41.57
-9.04%
45.70
Reconciled Cost Of Revenue
29.00
+37.05%
21.16
-26.52%
28.80
-12.98%
33.10
Gross Profit
935.61
-3.38%
968.29
+16.63%
830.23
-44.55%
1,497.15
Operating Expense
395.83
-31.92%
581.45
-22.36%
748.95
+51.77%
493.47
Selling General And Administration
130.43
-2.51%
133.79
-8.10%
145.59
-9.29%
160.49
General And Administrative Expense
130.43
-2.51%
133.79
-8.10%
145.59
-9.29%
160.49
Other Gand A
130.43
-2.51%
133.79
-8.10%
145.59
-9.29%
160.49
Total Expenses
432.25
-28.99%
608.70
-23.00%
790.51
+46.62%
539.17
Operating Income
539.77
+39.53%
386.85
+375.92%
81.28
-91.90%
1,003.68
EBITDA
812.59
-3.33%
840.60
+20.53%
697.41
-48.31%
1,349.26
Normalized EBITDA
1,000.99
-54.24%
2,187.30
+103.26%
1,076.13
-0.44%
1,080.88
Reconciled Depreciation
272.82
-39.87%
453.75
-26.35%
616.13
+78.29%
345.58
EBIT
539.77
+39.53%
386.85
+375.92%
81.28
-91.90%
1,003.68
Total Unusual Items
-188.40
+86.01%
-1,346.71
-255.59%
-378.72
-241.11%
268.38
Total Unusual Items Excluding Goodwill
-188.40
+86.01%
-1,346.71
-255.59%
-378.72
-241.11%
268.38
Special Income Charges
-193.95
+89.38%
-1,825.40
-384.31%
-376.91
-40.44%
-268.38
Impairment Of Capital Assets
193.95
-89.38%
1,825.40
+384.31%
376.91
+40.44%
268.38
Net Income
-277.05
+88.51%
-2,410.27
-333.13%
-556.48
-161.65%
902.60
Pretax Income
-237.32
+89.96%
-2,364.19
-244.25%
-686.77
-171.56%
959.72
Net Non Operating Interest Income Expense
-513.99
-21.77%
-422.12
-2.73%
-410.89
-11.51%
-368.49
Net Interest Income
-513.99
-21.77%
-422.12
-2.73%
-410.89
-11.51%
-368.49
Other Income Expense
-263.10
+88.70%
-2,328.92
-552.05%
-357.17
-210.06%
324.52
Other Non Operating Income Expenses
-172.55
+71.97%
-615.57
-8214.49%
7.59
-50.56%
15.34
Gain On Sale Of Security
5.54
-98.84%
478.69
+26474.27%
-1.81
-100.34%
536.75
Tax Provision
38.62
-12.43%
44.10
+133.75%
-130.68
-333.77%
55.90
Tax Rate For Calcs
0.00
+0.00%
0.00
+10.36%
0.00
+226.68%
0.00
Tax Effect Of Unusual Items
-39.56
+86.01%
-282.81
-292.44%
-72.06
-561.00%
15.63
Net Income Including Noncontrolling Interests
-275.94
+88.54%
-2,408.29
-333.07%
-556.09
-161.53%
903.82
Net Income From Continuing Operation Net Minority Interest
-277.05
+88.51%
-2,410.27
-333.13%
-556.48
-161.65%
902.60
Net Income From Continuing And Discontinued Operation
-277.05
+88.51%
-2,410.27
-333.13%
-556.48
-161.65%
902.60
Net Income Continuous Operations
-275.94
+88.54%
-2,408.29
-333.07%
-556.09
-161.53%
903.82
Minority Interests
-1.11
+43.95%
-1.98
-416.67%
-0.38
+68.58%
-1.22
Normalized Income
-128.21
+90.48%
-1,346.37
-438.94%
-249.82
-138.44%
649.85
Net Income Common Stockholders
-277.94
+88.47%
-2,411.22
-332.02%
-558.12
-161.94%
901.00
Otherunder Preferred Stock Dividend
0.89
-6.03%
0.95
-42.46%
1.64
+2.62%
1.60
Diluted EPS
—
-4.02
-332.26%
-0.93
-162.00%
1.50
Basic EPS
—
-4.02
-332.26%
-0.93
-162.00%
1.50
Basic Average Shares
—
600.25
+0.29%
598.52
-0.02%
598.63
Diluted Average Shares
—
600.25
+0.29%
598.52
-0.05%
598.84
Diluted NI Availto Com Stockholders
-277.94
+88.47%
-2,411.22
-332.02%
-558.12
-161.94%
901.00
Depreciation Amortization Depletion Income Statement
265.40
-40.71%
447.66
-25.81%
603.36
+81.20%
332.98
Depreciation And Amortization In Income Statement
265.40
-40.71%
447.66
-25.81%
603.36
+81.20%
332.98
Earnings From Equity Interest
97.85
+126.69%
-366.64
-2725.06%
13.97
-65.77%
40.80
Total Other Finance Cost
513.99
+21.77%
422.12
+2.73%
410.89
+11.51%
368.49
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
15,001.77
+4.95%
14,294.59
-21.91%
18,304.84
-6.88%
19,658.00
Current Assets
1,815.84
+38.22%
1,313.71
-5.99%
1,397.39
-18.86%
1,722.22
Cash Cash Equivalents And Short Term Investments
540.86
+62.75%
332.33
+32.93%
250.02
+6.09%
235.67
Cash And Cash Equivalents
540.86
+62.75%
332.33
+32.93%
250.02
+6.09%
235.67
Receivables
1,086.95
+28.44%
846.28
-13.08%
973.66
-17.63%
1,182.04
Accounts Receivable
900.66
+22.19%
737.11
+8.23%
681.05
-28.63%
954.20
Loans Receivable
186.29
+70.64%
109.17
-62.69%
292.62
+28.43%
227.84
Prepaid Assets
188.02
+39.18%
135.09
-22.23%
173.71
-42.96%
304.52
Total Non Current Assets
13,185.94
+1.58%
12,980.88
-23.22%
16,907.46
-5.73%
17,935.78
Investments And Advances
1,721.96
+7.89%
1,595.97
-50.94%
3,253.09
+10.55%
2,942.78
Long Term Equity Investment
1,721.96
+7.89%
1,595.97
-50.94%
3,253.09
+10.55%
2,942.78
Non Current Deferred Assets
3.27
-42.47%
5.67
-33.34%
8.51
-29.27%
12.04
Other Non Current Assets
372.75
+12.74%
330.64
+19.93%
275.69
+7.51%
256.44
Total Liabilities Net Minority Interest
10,394.53
+9.87%
9,460.81
-11.34%
10,670.98
-3.55%
11,063.59
Current Liabilities
1,206.46
+42.71%
845.38
-56.97%
1,964.56
+24.45%
1,578.63
Payables And Accrued Expenses
549.11
+20.89%
454.21
+10.20%
412.18
-33.66%
621.32
Current Debt And Capital Lease Obligation
638.06
+76.39%
361.73
-76.11%
1,514.42
+62.91%
929.58
Current Debt
638.06
+76.39%
361.73
-76.11%
1,514.42
+62.91%
929.58
Current Deferred Liabilities
19.29
-34.49%
29.45
-22.44%
37.96
+36.91%
27.73
Current Deferred Revenue
19.29
-34.49%
29.45
-22.44%
37.96
+36.91%
27.73
Total Non Current Liabilities Net Minority Interest
9,188.07
+6.65%
8,615.43
-1.05%
8,706.42
-8.21%
9,484.96
Long Term Debt And Capital Lease Obligation
9,188.07
+6.65%
8,615.43
-1.05%
8,706.42
-8.21%
9,484.96
Long Term Debt
9,059.77
+6.76%
8,486.39
-0.74%
8,549.82
-8.45%
9,338.83
Long Term Capital Lease Obligation
128.30
-0.58%
129.04
-17.60%
156.60
+7.17%
146.13
Stockholders Equity
4,606.19
-4.69%
4,832.73
-36.67%
7,631.60
-11.19%
8,592.84
Common Stock Equity
4,606.19
-4.69%
4,832.73
-36.67%
7,631.60
-11.19%
8,592.84
Capital Stock
0.60
-0.50%
0.60
+0.17%
0.60
+0.34%
0.60
Common Stock
0.60
-0.50%
0.60
+0.17%
0.60
+0.34%
0.60
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
597.01
-0.57%
600.40
+0.24%
598.99
+0.25%
597.48
Ordinary Shares Number
597.01
-0.57%
600.40
+0.24%
598.99
+0.25%
597.48
Additional Paid In Capital
8,573.40
-0.13%
8,584.92
+0.29%
8,560.31
+0.29%
8,535.14
Retained Earnings
-4,136.01
-13.05%
-3,658.52
-276.46%
-971.81
-935.71%
116.28
Gains Losses Not Affecting Retained Earnings
168.21
+278.43%
-94.27
-321.81%
42.50
+171.81%
-59.18
Treasury Stock
—
—
—
—
Minority Interest
1.05
+0.00%
1.05
-53.47%
2.27
+44.36%
1.57
Other Equity Adjustments
168.21
+278.43%
-94.27
-321.81%
42.50
+171.81%
-59.18
Total Equity Gross Minority Interest
4,607.25
-4.69%
4,833.78
-36.68%
7,633.86
-11.18%
8,594.41
Total Capitalization
13,665.97
+2.60%
13,319.11
-17.69%
16,181.42
-9.76%
17,931.67
Working Capital
609.38
+30.12%
468.33
+182.57%
-567.17
-495.00%
143.59
Invested Capital
14,304.03
+4.56%
13,680.84
-22.69%
17,695.84
-6.18%
18,861.25
Total Debt
9,826.13
+9.46%
8,977.16
-12.17%
10,220.84
-1.86%
10,414.54
Net Debt
9,156.98
+7.53%
8,515.78
-13.23%
9,814.22
-2.18%
10,032.74
Capital Lease Obligations
128.30
-0.58%
129.04
-17.60%
156.60
+7.17%
146.13
Net Tangible Assets
4,606.19
-4.69%
4,832.73
-36.67%
7,631.60
-11.19%
8,592.84
Tangible Book Value
4,606.19
-4.69%
4,832.73
-36.67%
7,631.60
-11.19%
8,592.84
Investment Properties
11,087.97
+0.36%
11,048.59
-17.36%
13,370.16
-9.20%
14,724.53
Investments In Other Ventures Under Equity Method
322.18
-26.71%
439.58
-75.29%
1,778.64
+23.10%
1,444.87
Investmentsin Joint Venturesat Cost
1,399.78
+21.05%
1,156.40
-21.57%
1,474.45
-1.57%
1,497.90
Line Of Credit
638.06
+76.39%
361.73
-76.11%
1,514.42
+62.91%
929.58
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
230.77
-5.99%
245.48
-51.47%
505.79
-31.56%
739.01
Cash Flow From Continuing Operating Activities
230.77
-5.99%
245.48
-51.47%
505.79
-31.56%
739.01
Net Income From Continuing Operations
-275.94
+88.54%
-2,408.29
-333.07%
-556.09
-161.53%
903.82
Depreciation Amortization Depletion
272.82
-39.87%
453.75
-26.35%
616.13
+78.29%
345.58
Depreciation And Amortization
272.82
-39.87%
453.75
-26.35%
616.13
+78.29%
345.58
Other Non Cash Items
-3.18
-100.76%
420.03
+28.80%
326.12
+251.48%
-215.29
Stock Based Compensation
25.75
-21.93%
32.98
-0.82%
33.25
-32.72%
49.42
Asset Impairment Charge
193.95
-91.33%
2,236.19
+493.30%
376.91
+40.44%
268.38
Deferred Tax
-11.23
-319.40%
5.12
+103.06%
-167.33
-1664.29%
10.70
Deferred Income Tax
-11.23
-319.40%
5.12
+103.06%
-167.33
-1664.29%
10.70
Operating Gains Losses
-5.54
+98.84%
-478.69
-26474.27%
1.81
+100.34%
-536.75
Gain Loss On Investment Securities
-5.54
+98.84%
-478.69
-26474.27%
1.81
+100.34%
-536.75
Change In Working Capital
34.15
+318.89%
-15.60
+87.52%
-125.01
-43.97%
-86.83
Change In Receivables
7.11
+155.98%
2.78
+101.96%
-141.73
-21.74%
-116.42
Change In Payables And Accrued Expense
21.68
-7.67%
23.48
+610.57%
-4.60
-113.70%
33.58
Change In Other Working Capital
-9.61
-67.01%
-5.75
-176.03%
7.57
+17497.67%
0.04
Change In Other Current Assets
14.97
+141.46%
-36.11
-362.61%
13.75
+441.28%
-4.03
Investing Cash Flow
-264.74
-120.08%
1,318.34
+154.72%
517.56
+30.68%
396.06
Cash Flow From Continuing Investing Activities
-264.74
-120.08%
1,318.34
+154.72%
517.56
+30.68%
396.06
Net Investment Purchase And Sale
-73.75
+52.75%
-156.08
+46.94%
-294.17
-41.84%
-207.39
Purchase Of Investment
-73.75
+52.75%
-156.08
+46.94%
-294.17
-41.84%
-207.39
Net Business Purchase And Sale
-142.09
-51.22%
-93.96
+57.82%
-222.76
+83.11%
-1,318.67
Purchase Of Business
-142.09
-34.53%
-105.62
+55.09%
-235.19
+82.36%
-1,332.96
Net Other Investing Changes
-89.44
+56.56%
-205.91
-181.90%
251.41
+263.02%
-154.22
Financing Cash Flow
228.08
+115.42%
-1,479.38
-44.99%
-1,020.33
+24.00%
-1,342.52
Cash Flow From Continuing Financing Activities
228.08
+115.42%
-1,479.38
-44.99%
-1,020.33
+24.00%
-1,342.52
Net Issuance Payments Of Debt
501.77
+390.11%
102.38
+124.36%
-420.25
+21.81%
-537.49
Issuance Of Debt
2,754.50
+242.52%
804.19
+41.60%
567.91
+71.00%
332.11
Repayment Of Debt
-2,252.73
-220.99%
-701.81
+28.98%
-988.16
-13.63%
-869.61
Long Term Debt Issuance
2,754.50
+242.52%
804.19
+41.60%
567.91
+71.00%
332.11
Long Term Debt Payments
-2,252.73
-220.99%
-701.81
+28.98%
-988.16
-13.63%
-869.61
Net Long Term Debt Issuance
501.77
+390.11%
102.38
+124.36%
-420.25
+21.81%
-537.49
Net Short Term Debt Issuance
—
—
567.91
+178.97%
203.58
Net Common Stock Issuance
-23.44
0.00
0.00
+100.00%
-17.94
Common Stock Payments
-23.44
0.00
0.00
+100.00%
-17.94
Common Stock Dividend Paid
-193.26
+39.81%
-321.08
+47.82%
-615.39
+11.90%
-698.53
Cash Dividends Paid
-193.26
+39.81%
-321.08
+47.82%
-615.39
+11.90%
-698.53
Repurchase Of Capital Stock
-23.44
0.00
0.00
+100.00%
-17.94
Proceeds From Stock Option Exercised
-2.47
+34.98%
-3.81
+52.90%
-8.08
+73.00%
-29.92
Net Other Financing Charges
-54.51
+95.66%
-1,256.87
-5472.63%
23.39
+139.90%
-58.63
Changes In Cash
194.11
+129.87%
84.44
+2698.97%
3.02
+101.45%
-207.46
Effect Of Exchange Rate Changes
14.71
+381.62%
-5.22
-145.84%
11.40
+188.44%
-12.89
Beginning Cash Position
335.17
+30.95%
255.95
+5.97%
241.54
-47.71%
461.88
End Cash Position
544.00
+62.30%
335.17
+30.95%
255.95
+5.97%
241.54
Free Cash Flow
230.77
-5.99%
245.48
-51.47%
505.79
-31.56%
739.01
Interest Paid Supplemental Data
458.23
+9.02%
420.31
+3.49%
406.14
+14.78%
353.84
Common Stock Issuance
—
—
0.00
0.00
Earnings Losses From Equity Investments
—
—
0.00
0.00
Interest Paid CFO
—
—
-141.73
-21.74%
-116.42
Issuance Of Capital Stock
—
—
0.00
0.00
Net Investment Properties Purchase And Sale
40.55
-97.71%
1,774.29
+126.58%
783.08
-62.29%
2,076.34
Purchase Of Investment Properties
-80.00
-0.27%
-79.79
+30.27%
-114.42
-4.75%
-109.24
Sale Of Business
0.00
-100.00%
11.66
-6.23%
12.43
-13.05%
14.29
Sale Of Investment Properties
120.55
-93.50%
1,854.08
+106.58%
897.50
-58.94%
2,185.57
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category